The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases".
Even as leading health experts have certified the vaccine to be safe and effective, the association of the vaccine with blood clots, severe side-effects and response against mutant virus variants has been a concern for many.
Over 1.22 lakh beneficiaries were administered the first dose of COVID-19 vaccine in a single-day in Rajasthan on Wednesday. Heath Secretary Siddharth Mahajan said that 1,22,030 frontline workers and 337 health workers got the jabs on Wednesday.
Over 1.22 lakh beneficiaries were administered the first dose of COVID-19 vaccine in a single-day in Rajasthan on Wednesday. Heath Secretary Siddharth Mahajan said that 1,22,030 frontline workers and 337 health workers got the jabs on Wednesday.
Over 1.22 lakh beneficiaries were administered the first dose of COVID-19 vaccine in a single-day in Rajasthan on Wednesday. Heath Secretary Siddharth Mahajan said that 1,22,030 frontline workers and 337 health workers got the jabs on Wednesday.